GE HealthCare Technologies (GEHC) DIvidends Date & History

Key Takeaways

• GE HealthCare Technologies Inc. (GEHC) offers a modest current dividend yield of 0.23% with an annual payout of $0.14 per share.
• Quarterly dividend payments have shown steady growth, rising from $0.03 in 2023-2024 to $0.035 since 2025.
• Extremely low payout ratio of approximately 3-4% indicates exceptional dividend sustainability backed by robust earnings.
• Free cash flow (FCF) of $1.72 billion (levered, TTM) provides ample coverage, representing just 2.38% of FCF used for dividends.
• Compared to healthcare equipment peers, GEHC's yield is low, prioritizing reinvestment over high income.
• Suitable for growth-oriented investors rather than those seeking immediate high yields.

Dividend Overview

GE HealthCare Technologies Inc. (GEHC), a leading provider of medical imaging, ultrasound, and patient care solutions, maintains a conservative dividend policy with quarterly payments. The current annual dividend stands at $0.14 per share, delivering a yield of 0.23% based on recent stock prices. The most recent quarterly dividend of $0.035 per share had an ex-dividend date of April 3, 2026, and was payable on May 15, 2026. This modest profile positions GEHC as neither a high-yield stock nor a traditional dividend growth contender, but rather a company focused on reinvesting profits into innovation and operations in the competitive healthcare technology sector.

Dividend History and Growth

Since its spin-off from General Electric in late 2022, GE HealthCare Technologies Inc. (GEHC) initiated dividends in 2023 at $0.03 per quarter, totaling $0.09 annually. Payments increased to $0.12 in 2024 and $0.14 in 2025, reflecting a roughly 7.7% year-over-year growth rate recently. The company has maintained consistent quarterly payouts without interruptions, with the latest increase to $0.035 occurring in 2025. While the growth streak is short—three years of payments—no cuts have occurred, signaling a commitment to shareholder returns amid business expansion.

Dividend Sustainability and Payout Ratio

The dividend for GE HealthCare Technologies Inc. (GEHC) is highly sustainable, with a payout ratio of 3.3-4.2% based on trailing twelve months (TTM) earnings per share (EPS) of $4.17. This low ratio leaves over 95% of earnings for reinvestment. Free cash flow coverage is equally strong, with levered FCF at $1.72 billion TTM covering the dividend multiple times (approximately 2.38% of FCF). Debt levels are manageable post-spin-off, and recent quarterly FCF generation supports ongoing payments. Overall financial stability in the healthcare equipment sector further bolsters confidence in continued payouts.

Dividend Compared to Industry Peers

In the healthcare equipment sector, GE HealthCare Technologies Inc. (GEHC)'s 0.23% yield trails established payers like Medtronic (MDT) at 3.64% (payout ratio 78.9%) and Abbott Laboratories (ABT) at around 2.8% (payout ratio ~55-68%). Growth-focused peers like Intuitive Surgical (ISRG) pay no dividend, reinvesting fully into expansion. The sector average yield hovers around 1.5-1.9%, making GEHC's offering low but reflective of its strategy emphasizing R&D and acquisitions over aggressive payouts.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It excels at identifying dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to uncover potential opportunities in healthcare and beyond.

Is This Stock Attractive for Dividend Investors?

GE HealthCare Technologies Inc. (GEHC) appeals to conservative, long-term dividend investors who prioritize sustainability over high current income. Its ultra-low payout ratio and strong FCF coverage make it resilient to economic pressures in the healthcare sector, where innovation drives growth. Those seeking modest yields with potential for gradual increases may find it suitable, especially given consistent quarterly payments since inception. However, income-focused investors pursuing yields above 2% might look elsewhere, as GEHC allocates most capital to R&D, acquisitions, and share repurchases—recently $100 million in buybacks. Growth-oriented dividend investors could benefit from total returns combining low yield, capital appreciation, and a safety net of robust earnings (TTM EPS $4.17). The profile suits portfolios emphasizing stability in medtech rather than immediate cash flow maximization, though it lacks the long dividend growth streaks of aristocrats like MDT or ABT.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations